Skip to content

Nigeria yet to achieve 70% COVID-19 immunisation coverage

ea dr faisal shuaib x
ea dr faisal shuaib x


By Abujah Racheal

Football Highlights

Nigeria is yet to meet its 70 percent target coverage with the COVID-19 vaccines, according to the Executive Secretary of the National Primary Health Care Development Agency (NPHCDA).

Dr Faisal Shuaib stated this in an interview with the News Agency of Nigeria (NAN) on Tuesday in Abuja.

He said; â€We are 21.6 million eligible persons away from reaching its target of fully vaccinating 70 per cent of its eligible population by December 2022.

â€But 62 per cent of the country’s eligible population is at least partially vaccinated against COVID-19.

â€As of Nov. 25, 56,790,371, total eligible persons targeted for COVID-19 vaccination are fully vaccinated while 12,492,646 of total eligible persons targeted for COVID-19 vaccination are partially vaccinated in 36 States and the FCT.

“The country has fully vaccinated half of the total population eligible for COVID-19 vaccination.

“WE have also fully vaccinated an additional over 25 per cent of its eligible population, in the last 110 days of SCALES 3.0 implementation,†he said.

The NPHCDA boss said that 13.2 per cent of fully vaccinated persons in the country have received the COVID-19 booster dose for additional protection against the virus.

He commended the COVID-19 Strategy Group for achieving 50 per cent vaccination coverage in the country. While attributing the success to the team working tirelessly.

Shuaib said he has also directed the team to intensify efforts towards the attainment of at least 70 per cent of the country’s targeted population to achieve herd immunity on COVID-19.

He also congratulated Nigeria for the feat and promised to sustain the momentum.

The NPHCDA boss said that the country’s target remains to hit 70 per cent of the targeted population.

“Until this is achieved, the strategy group will continue to develop strategies that will help the country achieve health security,†he said.

SEE IT HERE